ArcticZymes AS is a Norwegian enzyme developer and manufacturer based in Tromsø, and part of ArcticZymes Technologies ASA. The company specializes in cold‑adapted and salt‑tolerant enzymes originating from marine sources, supplying high‑performance biocatalysts to the life science, molecular diagnostics, and bioprocessing sectors.
Its portfolio includes specialty nucleases, phosphatases (such as shrimp alkaline phosphatase), and uracil‑DNA glycosylases used in applications spanning PCR and NGS cleanup, sample preparation, and nucleic‑acid removal in biomanufacturing workflows for gene therapy vectors and vaccines. Products are available in research, IVD, and GMP grades, with quality systems aligned to the needs of regulated markets. ArcticZymes AS also supports customers with technical expertise and scale‑up capabilities for integration of enzymes into industrial processes.
None yet. When a new project in the record names ArcticZymes AS as owner, partner or investor, it shows here.
The agreement enables wider access to salt-active nucleases for bioprocessing, enhancing product yield and reducing costs in gene therapy and vaccine production.
